Frontlight ResearchEarly access
Trial site
Icon Cancer Centre - Mount Alvernia
- 1running trial
- 1closed trial
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Phase
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Inhibrx Biosciences, Inc1 trial
- Taiho Oncology, Inc.1 trial
Running trials
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026